Nature 515 (7526), 279282
Among weight-loss pharmacotherapies, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including dual GLP-1 and glucose-dependent insulinotrophic polypeptide (GIP) receptor agonists, have demonstrated efficacy in patients with and without CKD, and are increasingly regarded as cornerstone therapies to improve outcomes in patients with multiple comorbidities
Infant implications of fiber inadequacy in the ketogenic diet: A case study
When taken as a supplement, L-Carnitine enters the bloodstream and supports the transport of fatty acids into cells for energy production
In this case, even though Sanitizer Supply is a contract manufacturer, FDA points out that they are still required to manufacture drugs in conformance with cGMP, regardless of any agreements with product owners
GLP-1 receptor agonists and risk of cancer in type 2 diabetes: An updated meta-analysis of randomized controlled trials